Correlations for H-scores of AR and ER expression in the lactiferous ducts {STT (r = 0.99) and the LTT groups (r = 0.93)}. by Jinho Lee (587173)

Subjects:

IHC Scores computer image analysis: Immunohistochemistry Scores and computer image analysis. by Jinho Lee (587173)

Subjects:

Significant interactions from mixed linear models of ECM colonization (Table 1). by Laura García de Jalón (8939456)

Family clades associating with week to treatment, symptom score or FC. by Katrine Carlsen (5477300)

Subjects:

Combination treatments increased p53 and decreased c-Myc levels in U-87MG and U-251MG cells more than did single treatments. by Panchanan Maiti (1459852)

“…<p>A-C: Western blot data showed that SLCP+BBR increased p53 and decreased c-Myc levels significantly more in U-87MG and U-251MG cells, in comparison to single treatments. …”

Rescue of vitellogenic growth in <i>bmp15-/-</i> females by E2 treatments. by Yue Zhai (3141960)

Subjects:

DataSheet1_Decreased Internal Phosphorus Loading From Eutrophic Sediment After Artificial Light Supplement: Preliminary Evidence From a Microcosm Experiment.docx by Miao Zhang (17216)

The effect of CWI on blood levels of (A) thyroid-stimulating hormone (TSH) and (B) testosterone in young healthy males. by Aneta Teległów (9570190)

Subjects:

Obese ZSF1 male rats exhibited increased BW, glucose, insulin, cholesterol, and triglyceride levels and decreased adiponectin and increased GDF15 levels. by Marina Stolina (9248633)

“…<p>Obese ZSF1 male rats at the age of 20 weeks exhibited increased body weight (A), elevated blood glucose (B), insulin (C), cholesterol (D), and triglyceride levels (E), decreased adiponectin (F), and increased growth differentiation factor 15 (GDF15) (G). …”

The hypoxia-induced changes of endothelial and fibrotic markers. by Jing Mao (148640)

Subjects:

The hypoxia-treated ECs were incubated with tamoxifen, the HIF-1α inhibitor, and the expression of CD31, α-SMA and fibronectin were detected. by Jing Mao (148640)

Subjects:

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

Subjects:

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

Subjects:

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

Subjects:

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

Subjects:

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

Subjects:

Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

Subjects:

Western blot analysis of PEX11B in different modes of treatment with DOX, EX-527 and GW9662. by Maryam Esmaeili (6457958)

Subjects:

Mylipb decreases tbk1-mediated irf3 phosphorylation and cellular antiviral response. by Zhi Li (72309)

“…(C) Overexpression of <i>mylipb</i> does not significantly disrupt the protein level of tbk1 in dose manner. …”

Changes in alpha diversity in the weeks before anti-TNF-a treatment. by Katrine Carlsen (5477300)

Subjects: